OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sodium glucose cotransporter 2 inhibitors and gout risk: a sequence symmetry analysis
D. Wood, Nancee V. Waterbury, Brian C. Lund
Clinical Rheumatology (2023) Vol. 42, Iss. 9, pp. 2469-2475
Closed Access | Times Cited: 9

Showing 9 citing articles:

Reducing hyperuricemic events with SGLT2 inhibitors: An updated systematic review with meta-regression
Hamlet Ghukasyan, Denilsa Navalha, Ignacio Pérez Romero, et al.
Endocrinología Diabetes y Nutrición (English ed ) (2025) Vol. 72, Iss. 1, pp. 26-36
Closed Access | Times Cited: 1

Identifying and quantifying potentially problematic prescribing cascades in clinical practice: A mixed‐methods study
Atiya K. Mohammad, Jacqueline G. Hugtenburg, Joost W. Vanhommerig, et al.
Journal of the American Geriatrics Society (2024)
Open Access | Times Cited: 3

Evaluating the Associated Hyperuricemia Risk with Sodium-Glucose Cotransporter 2 Inhibitors: A Sequence Symmetry Analysis Using the Japanese Administrative Claims Database
S. Yokoyama, Chihiro NAKAGAWA, Takaya Uno, et al.
Biological and Pharmaceutical Bulletin (2024) Vol. 47, Iss. 11, pp. 1851-1857
Open Access | Times Cited: 1

Risk of gout flare after medication: prescription symmetry sequence analysis
Shih‐Wei Lai, Bing‐Fang Hwang, Yu‐Hung Kuo, et al.
Clinical Rheumatology (2024) Vol. 43, Iss. 3, pp. 1183-1188
Closed Access

Glucagon-like peptide-1 receptor agonists: Prospects for use in rheumatology
Е. Л. Насонов, Т. С. Паневин, Е. А. Трошина
Rheumatology Science and Practice (2024) Vol. 62, Iss. 2, pp. 135-144
Open Access

Reducing hyperuricemic events with SGLT2 inhibitors: An updated systematic review with meta-regression
Hamlet Ghukasyan, Denilsa Navalha, Ignacio Pérez Romero, et al.
Endocrinología Diabetes y Nutrición (2024)
Closed Access

Contemporary prospects for the use of sodium-glucose cotransporter-2 inhibitors
Anastasia R. Kondratieva, E. A. Khazova, Alina Vadimovna Lobanova, et al.
Perm Medical Journal (2024) Vol. 41, Iss. 6, pp. 92-108
Open Access

Comment on “Sodium glucose cotransporter 2 inhibitors and gout risk”
Shih‐Wei Lai, Bing‐Fang Hwang, Chiu‐Shong Liu, et al.
Clinical Rheumatology (2023) Vol. 43, Iss. 2, pp. 835-836
Closed Access

Page 1

Scroll to top